SCHEMBL24028013

SCHEMBL24028013

Clc1ccc2c(c1)C1(c3ccccc3O2)c2ccccc2-c2cccc(Br)c21

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 1/20 0.38
PDK2 Q15119 3/20 0.37
AHR P35869 4/20 0.34
AKR1A1 P14550 1/20 0.34
AKR1B1 P15121 1/20 0.34
DRD2 P14416 4/20 0.32
DRD4 P21917 4/20 0.32
HRH4 Q9H3N8 2/20 0.32
HTR2A P28223 2/20 0.31
HRH1 P35367 2/20 0.31
CHRM2 P08172 1/20 0.31
HTR1A P08908 1/20 0.31
ADRA2A P08913 1/20 0.31
GABRA1 P14867 1/20 0.31
ADRA2B P18089 1/20 0.31
ADRA2C P18825 1/20 0.31
DRD1 P21728 1/20 0.31
SLC6A2 P23975 1/20 0.31
ADRA1D P25100 1/20 0.31
HTR2C P28335 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15713462 0.87 PDK2 (0.35) MAPK1PDK2AHRMAPT
SCHEMBL31753805 0.86 MAPK1 (0.45) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL22891353 0.86 MAPK1 (0.45) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL20687316 0.84 PDK2 (0.46) PDK2AKR1A1AKR1B1MAPT
SCHEMBL17816867 0.84 MAPK1 (0.44) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL26884817 0.84 PDK2 (0.46) PDK2AKR1A1AKR1B1MAPT
SCHEMBL21343865 0.83 PDK2 (0.38) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL21342825 0.82 AHR (0.41) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL21517441 0.82 AHR (0.41) MAPK1PDK2AHRAKR1A1AKR1B1
SCHEMBL23802650 0.81 PDK2 (0.35) MAPK1PDK2AHRMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230247899-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2023-08-03 US disclosed
US-20230247899-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR DUK SAN NEOLUX CO., LTD. (KR) 2023-08-03 US disclosed
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-27 US disclosed
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-27 US disclosed
WO-2022139445-A1 ORGANIC ELECTRIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRIC ELEMENT, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2022-06-30 WO disclosed
WO-2022010302-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR 덕산네오룩스 주식회사 2022-01-13 WO disclosed
WO-2021230650-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF 덕산네오룩스 주식회사 2021-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230247899-A1 ORGANIC ELECTRONIC ELEMENT CONTAINING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREFOR SLC39A11, LEF1, SLC39A14 MAPK1 181/4885PDK2 1499/4885AHR 1453/4885
US-20230240141-A1 ORGANIC ELECTRONIC ELEMENT COMPRISING COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE THEREOF ESR1, GPX1, LEF1 MAPK1 190/4885PDK2 2305/4885AHR 1108/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.